HLB Therapeutics Co Ltd 115450
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 6,390.00
- Day Range
- KRW 6,440.00–6,850.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 6,520.00 / KRW 6,540.00
- Market Cap
- KRW 498.17 Bil
- Volume/Avg
- 378,403 / 4.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.55
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 76
Comparables
Valuation
|
Metric
|
115450
|
321550
|
226950
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.80 | 2.78 | 7.74 |
Price/Sales | 8.55 | 35.15 | 13.76 |
Price/Cash Flow | — | — | — |
Price/Earnings
115450
321550
226950
Financial Strength
|
Metric
|
115450
|
321550
|
226950
|
|---|---|---|---|
Quick Ratio | — | — | 4.82 |
Current Ratio | 1.64 | 4.52 | 5.80 |
Interest Coverage | −2.63 | −7.20 | −4.92 |
Quick Ratio
115450
321550
226950
Profitability
|
Metric
|
115450
|
321550
|
226950
|
|---|---|---|---|
Return on Assets (Normalized) | −5.29% | −15.28% | −18.88% |
Return on Equity (Normalized) | −7.14% | −34.91% | −52.41% |
Return on Invested Capital (Normalized) | −5.72% | −17.65% | −20.04% |
Return on Assets
115450
321550
226950
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vwrwqflxj | Wyjr | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Vcqbrxg | Qgvxtq | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Rwxnmvypq | Rjcbm | $108.2 Bil | |
MRNA
| Moderna Inc | Lgclczcn | Hqdg | $50.9 Bil | |
ARGX
| argenx SE ADR | Wwqdmtgz | Jzlf | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Httnwqkmv | Tdhbh | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ytjxrld | Byybqrh | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Ljbhqnm | Skzcvbt | $14.6 Bil | |
INCY
| Incyte Corp | Hjbkjpz | Tckbzf | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vmyrqgqcy | Fvhtqh | $12.3 Bil |